苦参碱通过SREBP信号通路调控脂质代谢抗肿瘤作用机制的研究

2区 医学 Q1 Medicine Advances in Cancer Research Pub Date : 2023-01-01 DOI:10.53388/2023623012
Fang-Hua Wu, Fei Huang, Yan Chen, Kui Chen, Chao Gong, Shen-Zhou Huang, Jiang-Yue Yu, Ruohuan Zhao, Peishuo Zhu, Li-Qun Wang
{"title":"苦参碱通过SREBP信号通路调控脂质代谢抗肿瘤作用机制的研究","authors":"Fang-Hua Wu, Fei Huang, Yan Chen, Kui Chen, Chao Gong, Shen-Zhou Huang, Jiang-Yue Yu, Ruohuan Zhao, Peishuo Zhu, Li-Qun Wang","doi":"10.53388/2023623012","DOIUrl":null,"url":null,"abstract":"Author contributions Fang-Hua Wu and Fei Huang wrote the original draft; Yan Chen, Kui Chen, Chao Gong, Shen-Zhou Huang, Jiang-Yue Yu, Ruo-Qin Zhao, Pei-Wen Zhu was responsible for reviewing, editing, and supervision; Li-Qun Wang was responsible for project administration, supervision and methodology. Competing interests The authors declare no conflicts of interest. Acknowledgments This work was supported by grants from the Natural Science Foundation of Fujian province (No. 2020J011181). Peer review information Cancer Advances thanks Huang Wei Ling, Huan-Tian Cui and other anonymous reviewers for their contribution to the peer review of this paper. Abbreviations SREBP: sterol regulatory element binding protein; HE: hematoxylin and eosin; qPCR: quantitative polymerase chain reaction; Srebf1: transcription factor 1; Acly: ATP citrate lyase; Acc: acetyl-Coenzyme A carboxylase alpha. Citation Wu FH, Huang F, Chen Y, et al. Study on the mechanism of the anti-tumor effects of matrine via regulation of lipid metabolism mediated by SREBP signaling pathway. Cancer Adv. 2023;6:12. doi: 10.53388/2023623012.","PeriodicalId":50875,"journal":{"name":"Advances in Cancer Research","volume":"44 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Study on the mechanism of the anti-tumor effects of matrine via regulation of lipid metabolism mediated by SREBP signaling pathway\",\"authors\":\"Fang-Hua Wu, Fei Huang, Yan Chen, Kui Chen, Chao Gong, Shen-Zhou Huang, Jiang-Yue Yu, Ruohuan Zhao, Peishuo Zhu, Li-Qun Wang\",\"doi\":\"10.53388/2023623012\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Author contributions Fang-Hua Wu and Fei Huang wrote the original draft; Yan Chen, Kui Chen, Chao Gong, Shen-Zhou Huang, Jiang-Yue Yu, Ruo-Qin Zhao, Pei-Wen Zhu was responsible for reviewing, editing, and supervision; Li-Qun Wang was responsible for project administration, supervision and methodology. Competing interests The authors declare no conflicts of interest. Acknowledgments This work was supported by grants from the Natural Science Foundation of Fujian province (No. 2020J011181). Peer review information Cancer Advances thanks Huang Wei Ling, Huan-Tian Cui and other anonymous reviewers for their contribution to the peer review of this paper. Abbreviations SREBP: sterol regulatory element binding protein; HE: hematoxylin and eosin; qPCR: quantitative polymerase chain reaction; Srebf1: transcription factor 1; Acly: ATP citrate lyase; Acc: acetyl-Coenzyme A carboxylase alpha. Citation Wu FH, Huang F, Chen Y, et al. Study on the mechanism of the anti-tumor effects of matrine via regulation of lipid metabolism mediated by SREBP signaling pathway. Cancer Adv. 2023;6:12. doi: 10.53388/2023623012.\",\"PeriodicalId\":50875,\"journal\":{\"name\":\"Advances in Cancer Research\",\"volume\":\"44 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Advances in Cancer Research\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.53388/2023623012\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"Medicine\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Cancer Research","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.53388/2023623012","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"Medicine","Score":null,"Total":0}
引用次数: 0

摘要

原稿由吴方华、黄飞撰写;陈岩、陈奎、龚超、黄申洲、于江月、赵若琴、朱培文负责审编、监督;王立群负责项目管理、监督和方法论。利益冲突作者声明不存在利益冲突。本研究得到福建省自然科学基金(No. 2020J011181)资助。Cancer Advances感谢黄伟凌、崔焕天等匿名审稿人对本文的同行评议做出的贡献。SREBP:固醇调节元件结合蛋白;HE:苏木精和伊红;qPCR:定量聚合酶链反应;Srebf1:转录因子1;Acly: ATP柠檬酸裂解酶;乙酰辅酶A羧化酶。引用本文吴富华,黄峰,陈勇,等。苦参碱通过SREBP信号通路调控脂质代谢抗肿瘤作用机制的研究。癌症杂志,2023;6:12。doi: 10.53388 / 2023623012。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Study on the mechanism of the anti-tumor effects of matrine via regulation of lipid metabolism mediated by SREBP signaling pathway
Author contributions Fang-Hua Wu and Fei Huang wrote the original draft; Yan Chen, Kui Chen, Chao Gong, Shen-Zhou Huang, Jiang-Yue Yu, Ruo-Qin Zhao, Pei-Wen Zhu was responsible for reviewing, editing, and supervision; Li-Qun Wang was responsible for project administration, supervision and methodology. Competing interests The authors declare no conflicts of interest. Acknowledgments This work was supported by grants from the Natural Science Foundation of Fujian province (No. 2020J011181). Peer review information Cancer Advances thanks Huang Wei Ling, Huan-Tian Cui and other anonymous reviewers for their contribution to the peer review of this paper. Abbreviations SREBP: sterol regulatory element binding protein; HE: hematoxylin and eosin; qPCR: quantitative polymerase chain reaction; Srebf1: transcription factor 1; Acly: ATP citrate lyase; Acc: acetyl-Coenzyme A carboxylase alpha. Citation Wu FH, Huang F, Chen Y, et al. Study on the mechanism of the anti-tumor effects of matrine via regulation of lipid metabolism mediated by SREBP signaling pathway. Cancer Adv. 2023;6:12. doi: 10.53388/2023623012.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Advances in Cancer Research
Advances in Cancer Research 医学-肿瘤学
CiteScore
10.00
自引率
0.00%
发文量
52
期刊介绍: Advances in Cancer Research (ACR) has covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. Advances in Cancer Research (ACR) has covered a remarkable period of discovery that encompasses the beginning of the revolution in biology. The first ACR volume came out in the year that Watson and Crick reported on the central dogma of biology, the DNA double helix. In the first 100 volumes are found many contributions by some of those who helped shape the revolution and who made many of the remarkable discoveries in cancer research that have developed from it.
期刊最新文献
Hereditary diffuse gastric cancer. Mass spectrometry based biomarkers for early detection of HCC using a glycoproteomic approach. Targeting the super elongation complex for oncogenic transcription driven tumor malignancies: Progress in structure, mechanisms and small molecular inhibitor discovery. Targeting epigenetic regulation for cancer therapy using small molecule inhibitors. Collaborative Spirit Drives the Field of Tumor Glycobiology: A Preface to Special Volume on Cancer Glycobiology.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1